P012: IL22 expression in intestinal immune cells is not augmented by AHR activation in health or Crohn’s disease
ECCO '19 Copenhagen
2019
P013: Novel immunomodulatory role of food bioactive peptide lunasin in the healthy human intestinal mucosa
ECCO '19 Copenhagen
2019
P014: Disruption of epithelial barrier function by coeliac peripheral blood mononuclear cells
ECCO '19 Copenhagen
2019
P015: PNAd+ and MAdCAM+ high endothelial venules correlate with disease activity in ulcerative colitis
ECCO '19 Copenhagen
2019
P016: Constitutive activity of the cation channel TRPM8 regulates monocyte to macrophage transition in humans to control intestinal inflammation
ECCO '19 Copenhagen
2019
P017: Transcriptional reprogramming of the HIF pathway is associated with inflammation and mucosal hypoxia in ulcerative colitis patients
ECCO '19 Copenhagen
2019
P018: Macrophage targeting contributes to the inhibitory effects of dihydroartemisinin on DSS-induced colitis
ECCO '19 Copenhagen
2019
P020: Regulation of intestinal epithelial homeostasis by the IBD risk gene CCNY
ECCO '19 Copenhagen
2019
P021: An electrochemiluminescence (ECL) immunoassay for the detection of antidrug antibodies against anti-mucosal addressin cell adhesion molecule (MAdCAM) monoclonal antibody SHP647
ECCO '19 Copenhagen
2019
P022: Galectin-3, galectin-9, and galectin-3 binding protein in patients with inflammatory bowel diseases
ECCO '19 Copenhagen
2019
P024: Plasma acetic acid, propanoic acid, and isobutyric acid are associated with treatment response in pouchitis patients treated with antibiotics
ECCO '19 Copenhagen
2019
P025: Comparison of abdominal lymph nodes between healthy volunteers and patients with Crohn’s disease
ECCO '19 Copenhagen
2019
P026: Establishment of an in vitro system to evaluate the therapeutic effect of the investigational drug on ulcerative colitis using human colonic organoids
ECCO '19 Copenhagen
2019
P027: Machine learning approaches to identify prognosis indicators from microbiome data
ECCO '19 Copenhagen
2019